The burgeoning popularity of retatrutide, initially for blood sugar control , is creating significant attention within the British Isles, prompting a notable shift in hormone trends. Availability these treatments remains a complex situation , with NHS coverage currently limited and private clinics offering treatment at a higher cost . Questions are